Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2025-D-1504
Documents
1
Total comments
42
all analyzed
Comment status
Open
Last activity
Jun 21, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherMar 9, 2026
Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection: Draft Guidance for IndustryClosed on May 9, 2026💬 42 comments